Literature DB >> 30206812

An Update On Medical Treatment for Intracerebral Hemorrhage.

Xiang Li1, Dongxia Feng2, Gang Chen3.   

Abstract

Entities:  

Year:  2018        PMID： 30206812     DOI： 10.1007/s12975-018-0664-5

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN： 1868-4483            Impact factor:   6.829


× No keyword cloud information.
  101 in total

1.  Targeting the immune system in intracerebral hemorrhage.

Authors:  Kevin N Sheth; Jonathan Rosand
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

2.  Intravascular Inflammation Triggers Intracerebral Activated Microglia and Contributes to Secondary Brain Injury After Experimental Subarachnoid Hemorrhage (eSAH).

Authors:  Etienne Atangana; Ulf C Schneider; Kinga Blecharz; Salima Magrini; Josephin Wagner; Melina Nieminen-Kelhä; Irina Kremenetskaia; Frank L Heppner; Britta Engelhardt; Peter Vajkoczy
Journal:  Transl Stroke Res       Date:  2016-08-01       Impact factor: 6.829

3.  Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury.

Authors:  Yan-Chun Wang; Peng-Fei Wang; Huang Fang; Jing Chen; Xiao-Yi Xiong; Qing-Wu Yang
Journal:  Stroke       Date:  2013-07-09       Impact factor: 7.914

Review 4.  Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation.

Authors:  Yu Zhou; Yanchun Wang; Jian Wang; R Anne Stetler; Qing-Wu Yang
Journal:  Prog Neurobiol       Date:  2013-11-26       Impact factor: 11.685

Review 5.  Iron and intracerebral hemorrhage: from mechanism to translation.

Authors:  Xiao-Yi Xiong; Jian Wang; Zhong-Ming Qian; Qing-Wu Yang
Journal:  Transl Stroke Res       Date:  2013-12-21       Impact factor: 6.829

6.  SRC kinase inhibition improves acute outcomes after experimental intracerebral hemorrhage.

Authors:  Timothy D Ardizzone; Xinhua Zhan; Brad P Ander; Frank R Sharp
Journal:  Stroke       Date:  2007-03-29       Impact factor: 7.914

Review 7.  Deferoxamine mesylate: a new hope for intracerebral hemorrhage: from bench to clinical trials.

Authors:  Magdy Selim
Journal:  Stroke       Date:  2008-12-08       Impact factor: 7.914

8.  Use of statins for the treatment of spontaneous intracerebral hemorrhage: results of a pilot study.

Authors:  H Tapia-Perez; M Sanchez-Aguilar; J G Torres-Corzo; I Rodriguez-Leyva; D Gonzalez-Aguirre; A Gordillo-Moscoso; C Chalita-Williams
Journal:  Cent Eur Neurosurg       Date:  2009-02-05

9.  TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice.

Authors:  Fang Hua; Huiling Tang; Jun Wang; Megan C Prunty; Xiaodong Hua; Iqbal Sayeed; Donald G Stein
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-31       Impact factor: 6.200

10.  Role for RIP1 in mediating necroptosis in experimental intracerebral hemorrhage model both in vivo and in vitro.

Authors:  Haitao Shen; Chenglin Liu; Dongping Zhang; Xiyang Yao; Kai Zhang; Haiying Li; Gang Chen
Journal:  Cell Death Dis       Date:  2017-03-02       Impact factor: 8.469
View more
  1 in total

1.  Molecular Correlates of Hemorrhage and Edema Volumes Following Human Intracerebral Hemorrhage Implicate Inflammation, Autophagy, mRNA Splicing, and T Cell Receptor Signaling.

Authors:  Marc Durocher; Bodie Knepp; Alan Yee; Glen Jickling; Fernando Rodriguez; Kwan Ng; Xinhua Zhan; Farah Hamade; Eva Ferino; Hajar Amini; Paulina Carmona-Mora; Heather Hull; Bradley P Ander; Frank R Sharp; Boryana Stamova
Journal:  Transl Stroke Res       Date:  2020-11-18       Impact factor: 6.829
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.